March 12, 2020 / 9:29 PM / 20 days ago

BRIEF-Homology Medicines Reports Q4 Loss Per Share Of $0.55

March 12 (Reuters) - Homology Medicines Inc:

* HOMOLOGY MEDICINES REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND RECENT ACCOMPLISHMENTS

* Q4 LOSS PER SHARE $0.55

* Q4 EARNINGS PER SHARE ESTIMATE $-0.68 — REFINITIV IBES DATA

* BASED ON CURRENT PROJECTIONS, HOMOLOGY EXPECTS CASH RESOURCES TO FUND OPERATIONS INTO THE FOURTH QUARTER OF 2021 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below